{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:55:23Z","timestamp":1792796123311,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["EVD-184698"],"award-info":[{"award-number":["EVD-184698"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000034","name":"Institute of Neurosciences Mental Health and Addiction","doi-asserted-by":"publisher","award":["REN-181677"],"award-info":[{"award-number":["REN-181677"]}],"id":[{"id":"10.13039\/501100000034","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.josat.2025.209815","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:06:43Z","timestamp":1761008803000},"page":"209815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The short-term impacts of the decriminalization of illegal drug possession on clients dispensed opioid agonist treatment medications and visits to supervised consumption services and overdose prevention services in British Columbia, Canada (2015\u20132023)"],"prefix":"10.1016","volume":"180","author":[{"given":"Sami Aftab","family":"Abdul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cayley","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Elton-Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farihah","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iesha","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Le Foll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Kinniburgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Rehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Imtiaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.josat.2025.209815_bb0005","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12961-024-01150-6","article-title":"Navigating the nexus between British Columbia\u2019s public consumption and decriminalization policies of illegal drugs","volume":"22","author":"Ali","year":"2024","journal-title":"Health Research Policy and Systems"},{"key":"10.1016\/j.josat.2025.209815_bb0010","series-title":"Trends in Drug Checking Results Across British Columbia: January to December 2023","author":"Angelucci","year":"2024"},{"issue":"1","key":"10.1016\/j.josat.2025.209815_bb0015","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12954-024-01075-x","article-title":"The fentanyl made me feel like I needed more methadone: Changes in the role and use of medication for opioid use disorder (MOUD) due to fentanyl","volume":"21","author":"Bolshakova","year":"2024","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.josat.2025.209815_bb0020","author":"British Columbia Centre for Disease Control"},{"key":"10.1016\/j.josat.2025.209815_bb0025","series-title":"A Guideline for the Clinical Management of Opioid Use Disorder: 2023 Update [Clinical Guideline]","author":"British Columbia Centre on Substance Use, BC Ministry of Health, & BC Ministry of Mental Health and Addictions","year":"2023"},{"key":"10.1016\/j.josat.2025.209815_bb0030","author":"British Columbia Coroners Service"},{"key":"10.1016\/j.josat.2025.209815_bb0035","author":"British Columbia Ministry of Mental Health and Addictions"},{"key":"10.1016\/j.josat.2025.209815_bb0040","author":"British Columbia Ministry of Mental Health and Addictions"},{"key":"10.1016\/j.josat.2025.209815_bb0045","series-title":"Methadone treatment for people who use fentanyl: Recommendations","author":"Bromley","year":"2021"},{"key":"10.1016\/j.josat.2025.209815_bb0050","series-title":"National Operational Guidance for the Implementation of Supervised Consumption Services","author":"Canadian Research Initiative in Substance Misuse (CRISM)","year":"2023"},{"key":"10.1016\/j.josat.2025.209815_bb0055","series-title":"The Bank of Canada COVID-19 Stringency Index: Measuring Policy Response Across Provinces (2021\u22121)","author":"Cheung","year":"2021"},{"key":"10.1016\/j.josat.2025.209815_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104155","article-title":"Changes in arrests following decriminalization of low-level drug possession in Oregon and Washington","volume":"119","author":"Davis","year":"2023","journal-title":"The International Journal on Drug Policy"},{"issue":"7","key":"10.1016\/j.josat.2025.209815_bb0065","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/0706743717711167","article-title":"The state of opioid agonist therapy in Canada 20 years after federal oversight","volume":"62","author":"Eibl","year":"2017","journal-title":"Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie"},{"issue":"3","key":"10.1016\/j.josat.2025.209815_bb0070","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/ADM.0000000000000476","article-title":"Evaluating the impact of prescribed versus nonprescribed benzodiazepine use in methadone maintenance therapy: Results from a population-based retrospective cohort study","volume":"13","author":"Eibl","year":"2019","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2025.209815_bb0075","series-title":"Opioid- and Stimulant-related Harms in Canada. [Public Health Report]","author":"Federal, Provincial, and Territorial Special Advisory Committee on Toxic Drug Poisonings","year":"2024"},{"key":"10.1016\/j.josat.2025.209815_bb0080","first-page":"1","article-title":"Going after the addiction, not the addicted: The impact of drug decriminalization in Portugal","volume":"10895","author":"F\u00e9lix","year":"2017","journal-title":"IZA \u2013 Institute of Labor Economics"},{"issue":"6","key":"10.1016\/j.josat.2025.209815_bb0085","doi-asserted-by":"crossref","first-page":"943","DOI":"10.17269\/s41997-023-00809-x","article-title":"\u201cDrug decriminalization\u201d in Canada: A plea for a nuanced, evidence-informed, and realistic approach towards improved health outcomes","volume":"114","author":"Fischer","year":"2023","journal-title":"Canadian Journal of Public Health = Revue Canadienne De Sant\u00e9 Publique"},{"key":"10.1016\/j.josat.2025.209815_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.lana.2023.100437","article-title":"The continuous opioid death crisis in Canada: Changing characteristics and implications for path options forward","volume":"19","author":"Fischer","year":"2023","journal-title":"Lancet Regional Health - Americas"},{"issue":"2","key":"10.1016\/j.josat.2025.209815_bb0095","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/dar.13796","article-title":"Three noteworthy idiosyncrasies related to Canada\u2019s opioid-death crisis, and implications for public health-oriented interventions","volume":"43","author":"Fischer","year":"2024","journal-title":"Drug and Alcohol Review"},{"issue":"1","key":"10.1016\/j.josat.2025.209815_bb0100","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12954-017-0134-5","article-title":"The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario","volume":"14","author":"Franklyn","year":"2017","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.josat.2025.209815_bb0105","series-title":"Overdose prevention","author":"Government of British Columbia","year":"2022"},{"key":"10.1016\/j.josat.2025.209815_bb0110","series-title":"Building better mental health and addictions care","author":"Government of British Columbia","year":"2024"},{"key":"10.1016\/j.josat.2025.209815_bb0115","series-title":"Decriminalizing people who use drugs in B.C","author":"Government of British Columbia","year":"2024"},{"key":"10.1016\/j.josat.2025.209815_bb0120","author":"Health Canada"},{"issue":"1","key":"10.1016\/j.josat.2025.209815_bb0125","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1874473711104010004","article-title":"Unemployment and substance use: A review of the literature (1990-2010)","volume":"4","author":"Henkel","year":"2011","journal-title":"Current Drug Abuse Reviews"},{"issue":"1","key":"10.1016\/j.josat.2025.209815_bb0130","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12954-023-00779-w","article-title":"\u201cAs long as that place stays open, I\u2019ll stay alive\u201d: Accessing injectable opioid agonist treatment during dual public health crises","volume":"20","author":"Jaffe","year":"2023","journal-title":"Harm Reduction Journal"},{"issue":"1","key":"10.1016\/j.josat.2025.209815_bb0135","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12874-022-01716-4","article-title":"Estimating effects of health policy interventions using interrupted time-series analyses: A simulation study","volume":"22","author":"Jiang","year":"2022","journal-title":"BMC Medical Research Methodology"},{"issue":"12","key":"10.1016\/j.josat.2025.209815_bb0140","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1001\/jamapsychiatry.2023.3416","article-title":"One-year association of drug possession law change with fatal drug overdose in Oregon and Washington","volume":"80","author":"Joshi","year":"2023","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.josat.2025.209815_bb0145","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/CXA.0000000000000221","article-title":"Unanticipated benzodiazepine withdrawal in the context of an adulterated unregulated opioid supply in Vancouver, BC: A case series","volume":"15","author":"Laing","year":"2024","journal-title":"Canadian Journal of Addiction"},{"key":"10.1016\/j.josat.2025.209815_bb0150","series-title":"Overdose prevention and supervised consumption sites and public substance use among people who use substances: Harm Reduction Client Survey 2023 [Knowledge Update]","author":"Loewen","year":"2024"},{"key":"10.1016\/j.josat.2025.209815_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2024.104478","article-title":"Decriminalization or police mission creep? Critical appraisal of law enforcement involvement in British Columbia, Canada\u2019s decriminalization framework","volume":"129","author":"Michaud","year":"2024","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2025.209815_bb0160","author":"Ontario HIV Treatment Network"},{"issue":"5","key":"10.1016\/j.josat.2025.209815_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252090","article-title":"Crystal methamphetamine use in British Columbia, Canada: A cross-sectional study of people who access harm reduction services","volume":"16","author":"Papamihali","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.josat.2025.209815_bb0170","doi-asserted-by":"crossref","DOI":"10.1186\/s13011-022-00463-5","article-title":"Barriers and facilitators to opioid agonist therapy in rural and remote communities in Canada: An integrative review","volume":"17","author":"Pijl","year":"2022","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"1","key":"10.1016\/j.josat.2025.209815_bb0175","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-024-20336-9","article-title":"The decriminalization of illicit drugs in British Columbia: A national evaluation protocol","volume":"24","author":"Russell","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.josat.2025.209815_bb0180","article-title":"Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study","volume":"129","author":"Russell","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2025.209815_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2024.104343","article-title":"Examining inequities in access to opioid agonist treatment (OAT) take-home doses (THD): A Canadian OAT guideline synthesis and systematic review","volume":"127","author":"Russell","year":"2024","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2025.209815_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103933","article-title":"The increase in benzodiazepine-laced drugs and related risks in Canada: The urgent need for effective and sustainable solutions","volume":"111","author":"Russell","year":"2023","journal-title":"The International Journal on Drug Policy"},{"issue":"1","key":"10.1016\/j.josat.2025.209815_bb0195","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13722-023-00402-0","article-title":"The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: A scoping review","volume":"18","author":"Russell","year":"2023","journal-title":"Addiction Science & Clinical Practice"},{"issue":"3","key":"10.1016\/j.josat.2025.209815_bb0200","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1177\/00914509231179226","article-title":"\u201cCriminalization causes the stigma\u201d: Perspectives from people who use drugs","volume":"50","author":"Scher","year":"2023","journal-title":"Contemporary Drug Problems"},{"issue":"3\u20134","key":"10.1016\/j.josat.2025.209815_bb0205","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/biomet\/52.3-4.591","article-title":"An analysis of variance test for normality (complete samples)\u2020","volume":"52","author":"Shapiro","year":"1965","journal-title":"Biometrika"},{"key":"10.1016\/j.josat.2025.209815_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102696","article-title":"Trajectories of retention in opioid agonist therapy in a Canadian setting","volume":"77","author":"Soc\u00edas","year":"2020","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.josat.2025.209815_bb0215","series-title":"Drug overdose deaths in the United States, 2002\u20132022","author":"Spencer","year":"2023"},{"key":"10.1016\/j.josat.2025.209815_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhealeco.2023.102798","article-title":"Does drug decriminalization increase unintentional drug overdose deaths?: Early evidence from Oregon Measure 110","volume":"91","author":"Spencer","year":"2023","journal-title":"Journal of Health Economics"},{"key":"10.1016\/j.josat.2025.209815_bb0225","series-title":"Table 14-10-0287-03 Labour force characteristics, monthly, seasonally adjusted and trend-cycle, last 5 months [Dataset]","author":"Statistics Canada","year":"2018"},{"key":"10.1016\/j.josat.2025.209815_bb0230","series-title":"Table 17-10-0005-01 Population estimates on July 1, by age and gender [Dataset]","author":"Statistics Canada","year":"2018"},{"issue":"1","key":"10.1016\/j.josat.2025.209815_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.nurpra.2023.104858","article-title":"Benzodiazepine withdrawal in the context of benzodiazepine-contaminated opioids: Practice implications","volume":"20","author":"Wilson","year":"2024","journal-title":"The Journal for Nurse Practitioners"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925001948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925001948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T04:33:58Z","timestamp":1773203638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875925001948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":47,"alternative-id":["S2949875925001948"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2025.209815","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The short-term impacts of the decriminalization of illegal drug possession on clients dispensed opioid agonist treatment medications and visits to supervised consumption services and overdose prevention services in British Columbia, Canada (2015\u20132023)","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2025.209815","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"209815"}}